Loading…
Atara Biotherapeutics, Inc. is projected to rise to $12.22 by 2027, a +25% move from its current price of $9.76. ATRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $9.38 | $9.77 | $10.17 | +0.08% |
| Jul 14 | $9.23 | $9.78 | $10.35 | +0.16% |
| Jul 15 | $9.12 | $9.78 | $10.50 | +0.24% |
| Jul 16 | $9.03 | $9.79 | $10.62 | +0.32% |
| Jul 17 | $8.95 | $9.80 | $10.73 | +0.40% |
| Jul 18 | $8.88 | $9.81 | $10.83 | +0.48% |
| Jul 19 | $8.81 | $9.81 | $10.93 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.81 | $9.81 | $10.93 | +0.56% |
| Week 2 | $8.48 | $9.87 | $11.49 | +1.12% |
| Week 3 | $8.24 | $9.92 | $11.95 | +1.68% |
| Week 4 | $8.05 | $9.98 | $12.37 | +2.25% |
| Week 5 | $7.89 | $10.03 | $12.76 | +2.81% |
| Week 6 | $7.76 | $10.09 | $13.13 | +3.39% |
| Week 7 | $7.64 | $10.15 | $13.48 | +3.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Atara Biotherapeutics, Inc. is a healthcare company that engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally.
Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases.
It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc.
was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Atara Biotherapeutics, Inc. (ATRA) is a healthcare stock positioned in the sector listed as Healthcare.
The stock currently trades near $10.26 per share with a market cap of $92.44M and a rank of 4264.
The current price outlook from the forecast shows an average of $10.26 in 2026 with a min of $4.18 and a max of $15.00, yielding a 0% ROI and a Neutral sentiment for that year.
From 2027 onward, the forecast envisions a bullish trajectory, with rising averages and higher potential highs: 2027 avg $12.97, 2028 avg $13.33, 2029 avg $19.94, 2030 avg $27.20, 2040 avg $84.37, and 2050 avg $213.57, along with progressively larger max values and positive sentiment.
A major floor 55.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 19.4% above — a clean break opens room to run.
A major ceiling 27.0% above — clearing it would confirm fresh momentum.
Key ATRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.10 | Sell | $10.11 | Sell |
| MA 10 | $10.67 | Sell | $10.35 | Sell |
| MA 20 | $10.47 | Sell | $10.33 | Sell |
| MA 50 | $9.47 | Buy | $9.43 | Buy |
| MA 100 | $7.27 | Buy | $8.81 | Buy |
| MA 200 | $9.89 | Sell | $9.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.36 | Neutral |
| Stoch RSI (14) | 5.88 | Buy |
| CCI (20) | -91.98 | Neutral |
| Williams %R (14) | -94.50 | Info |
| MACD (12,26,9) | -0.21 | Sell |
| ROC (12) | -12.54 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 5.50 | Buy |
| TRIX (15) | 0.60 | Buy |
| Awesome (5,34) | -0.19 | Sell |
| Ultimate (7,14,28) | 31.65 | Neutral |
| Momentum (10) | -0.46 | Sell |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 9.47 | Buy |
| ADX (14) | 16.48 | Neutral |
| ATR (14) | 0.41 | Info |
The 30-day technical picture shows a bullish tilt for ATARA on balance.
RSI(14) is 50, with the 50-day simple moving average at $9.17 and the 200-day simple moving average at $9.93, suggesting price is hovering near key levels.
Support is reported at $9.58 and resistance at $11.65, with the 30-day range spanning from $7.79 to $13.52.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.18 | $9.76 | $14.10 | 0% | Neutral | |
| $9.29 | $12.22 | $17.25 | +25% | Bullish | |
| $8.97 | $12.33 | $18.32 | +26% | Bullish | |
| $12.68 | $18.08 | $27.95 | +85% | Bullish | |
| $16.64 | $24.53 | $39.19 | +151% | Bullish | |
| $18.02 | $27.37 | $45.00 | +180% | Bullish | |
| $21.16 | $33.08 | $55.78 | +239% | Bullish | |
| $20.89 | $33.56 | $57.91 | +244% | Bullish | |
| $21.45 | $35.36 | $62.31 | +262% | Bullish | |
| $24.35 | $41.17 | $73.97 | +322% | Bullish | |
| $38.19 | $72.66 | $141.48 | +644% | Bullish | |
| $80.66 | $179.24 | $391.35 | +17.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.18 | $9.76 | $11.73 | +0.00% |
| August 2026 | $8.52 | $10.19 | $12.61 | +4.42% |
| September 2026 | $8.68 | $10.49 | $13.20 | +2.96% |
| October 2026 | $8.40 | $10.25 | $13.06 | -2.34% |
| November 2026 | $8.44 | $10.38 | $13.38 | +1.27% |
| December 2026 | $8.74 | $10.83 | $14.10 | +4.34% |
Click any year to see its month-by-month ATRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ATRA price prediction for 2026 points to an average of $9.76 (low $4.18, high $14.10) — a potential gain of 0% on today's $9.76. A consolidation phase looks the most probable path here.
In 2027, ATRA is projected to trade between $9.29 and $17.25, averaging $12.22 — a potential gain of +25% from today's $9.76. That is up +25% on the projected 2026 average. Momentum favours further upside here.
Atara Biotherapeutics, Inc.'s 2028 outlook centres on $12.33, within a $8.97 to $18.32 range. That is up +1% on the projected 2027 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ATRA could reach as high as $27.95, with a base case around $18.08 and support toward $12.68 — roughly +85% from $9.76. Momentum favours further upside here.
Expect ATRA to range from $16.64 to $39.19 through 2030. The $24.53 average target implies a +151% move from current prices. That is up +36% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ATRA price prediction for 2031 points to an average of $27.37 (low $18.02, high $45.00) — a potential gain of +180% on today's $9.76. Momentum favours further upside here.
In 2032, ATRA is projected to trade between $21.16 and $55.78, averaging $33.08 — a potential gain of +239% from today's $9.76. That is up +21% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Atara Biotherapeutics, Inc.'s 2033 outlook centres on $33.56, within a $20.89 to $57.91 range. That is up +1% on the projected 2032 average. That marks a +244% change versus current levels. Momentum favours further upside here.
By 2034, ATRA could reach as high as $62.31, with a base case around $35.36 and support toward $21.45 — roughly +262% from $9.76. Buyers look set to stay in control over this stretch.
Expect ATRA to range from $24.35 to $73.97 through 2035. The $41.17 average target implies a +322% move from current prices. That is up +16% on the projected 2034 average. Momentum favours further upside here.
The ATRA price prediction for 2040 points to an average of $72.66 (low $38.19, high $141.48) — a potential gain of +644% on today's $9.76. Buyers look set to stay in control over this stretch.
In 2050, ATRA is projected to trade between $80.66 and $391.35, averaging $179.24 — a potential gain of +17.4x from today's $9.76. That is up +147% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ATRA today (≈ 102.459016 ATRA) could be worth
$18,364.32
+$17,364.32 (+1736%) by 2050 · US Dollar
Based on the average projected ATRA price of $179.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATRAwould be worth at today's price.
$1,000 invested in ATRA on Jul 10, 2025 (≈ 105.485237 ATRA) would be worth
$1,029.54
+$29.54 (+3.0%) today · 1.03× · US Dollar
Based on a ATRA entry price of $9.48 vs. today's $9.76.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.65 | $837.77 | -16.2% |
| 1 month ago | $9.86 | $989.86 | -1.0% |
| 3 months ago | $4.65 | $2,098.92 | +109.9% |
| 6 months ago | $5.88 | $1,659.86 | +66.0% |
| 1 year ago | $9.48 | $1,029.54 | +3.0% |
| All time (5.0y) ago | $344.25 | $28.35 | -97.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATRA forecast.
Our base-case forecast reaches $20.00 around 2030.
Implied market cap at $20.00: $180.2M
The multi-year forecast lays out a clear bullish trajectory, with substantial upside from the current level over the next several years. In 2030 the avg price is forecast at $27.20 with a max of $43.84 and a min of $18.29, corresponding to a 165.1% ROI and a bullish sentiment.
Looking further, the forecast shows a steep rise by 2040 to an avg of $84.37 and a max of $166.37, delivering a 722.3% ROI and continued bullish sentiment.
By 2050 the avg is projected to $213.57 with a max of $473.20 and a min of $96.11, representing a 1981.6% ROI and a bullish stance.
These figures are estimates, not guarantees, and actual results will depend on factors beyond what is shown here.
Tap a question to reveal the answer.
The forecast for 2030 shows an avg of $27.20 with a min of $18.29 and a max of $43.84, corresponding to a 165.1% ROI and a bullish sentiment.
Forecasts indicate a path from 2026 with an avg of $10.26 (ROI 0) to higher averages in 2027–2029 and beyond, with bullish sentiment in later years. These are estimates, not guarantees.
Yes. The forecast lists a 2031 max of $50.63, indicating a possible peak near or above $50 in that year.
The 30-day range is $7.79 to $13.52, RSI(14) is 50, SMA50 is $9.17, SMA200 is $9.93, with support at $9.58 and resistance at $11.65.
The 2050 forecast shows an avg of $213.57, a min of $96.11, a max of $473.20, a ROI of 1981.6%, and a bullish sentiment.
Atara Biotherapeutics, Inc. Community Discussion
0Share your Atara Biotherapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.